| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | EVP, Global Research And CSO
1 company
Altshuler David is an EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 28 sells.
Estimated insider holdings value: $10.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 3,002 | $421.77 | $1,266,153.54 | -8.1% | +5.3% | +14.5% | |
| Feb 20, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 4,002 | $420.79 | $1,684,001.58 | -9.8% | +6.0% | +12.2% | |
| Feb 12, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 3,145 | $420.24 | $1,321,654.80 | -6.2% | +2.7% | +8.8% | |
| Nov 15, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 19 | $369.92 | $7,028.48 | - | +19.1% | +38.5% | |
| Aug 9, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 63 | $345.51 | $21,767.13 | -0.2% | +9.6% | +35.0% | |
| Feb 27, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 4,238 | $287.51 | $1,218,449.48 | -4.2% | +13.2% | +49.9% | |
| Feb 21, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 4,002 | $293.77 | $1,175,676.13 | -2.3% | +16.2% | +43.5% | |
| Feb 14, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 6,398 | $298.70 | $1,911,107.89 | -2.1% | +16.1% | +39.2% | |
| Feb 13, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 4,798 | $298.90 | $1,434,126.48 | -2.1% | +16.5% | +39.1% | |
| Feb 6, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 1,304 | $306.00 | $399,021.78 | -0.3% | +12.9% | +36.5% |